Security readout for executives and security teams
Plain-English summary
LabCup before the fixed release allowed a user without user-management privileges to alter another user's email address through the save API under specific knowledge conditions. Successful abuse could let the attacker gain access to the victim's account. Public scoring and affected product metadata are incomplete in the bundle.
Executive priority
Treat this as high priority where LabCup is internet-accessible or broadly available internally, because the reported outcome is account takeover. Prioritize version verification, upgrade planning, and audit review over broad emergency response unless local evidence suggests abuse.
Technical view
CVE-2021-33031 describes an authorization flaw in LabCup's save API before v2_next_18022, fixed in 6.3.0.03. A non-privileged user could perform unauthorized account-management actions if they knew exact victim account attributes, including roles, group roles, ID, and remote-authentication settings.
Likely exposure
Exposure appears limited to organizations running LabCup versions before v2_next_18022 or before the stated fixed version 6.3.0.03. The bundle does not provide CPEs, deployment patterns, or vendor-wide affected version ranges beyond LabCup.
Exploitation context
The bundle does not show CISA KEV listing or public active exploitation. Abuse requires authenticated access and detailed knowledge of the target user's account attributes, but the stated impact is potential victim account access.
Researcher notes
Evidence is thin: no CVSS, CWE, CPE, or detailed advisory is included. The key condition is improper authorization on the save API, constrained by attacker knowledge of victim account fields. Do not assume broader LabCup components are affected without vendor confirmation.
Mitigation direction
- Upgrade LabCup to 6.3.0.03 or a vendor-confirmed fixed release.
- Check LabCup vendor guidance for any additional remediation instructions.
- Review recent account email changes for unauthorized modifications.
- Restrict LabCup access to trusted users until remediation is complete.
- Validate user-management permissions after upgrade.
Validation and detection
- Inventory LabCup deployments and record exact installed versions.
- Confirm whether each deployment is before v2_next_18022 or 6.3.0.03.
- Review audit logs for unexpected user email changes.
- Verify non-user-management accounts cannot modify other users.
- Check remote-authentication settings for unexpected account changes.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CVE-2021-33031 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS and timeline data
No CVSS vectors or timeline events were available in the normalized CVE source material.
Source materials
- CVE List V5 sourceCVE List V5
- https://github.com/Accenture/AARO-Bugs/blob/master/AARO-CVE-List.mdCVE reference · x_refsource_MISC
- https://labcup.net/privacy-data-security/CVE reference · x_refsource_MISC
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.